Stocks and Investing Stocks and Investing
Wed, December 19, 2012
[ Wed, Dec 19th 2012 ] - Market Wire
Closes Initial Public Offering
Tue, December 18, 2012
[ Tue, Dec 18th 2012 ] - Market Wire
3.81 g/t Au Over 41 Meters
Mon, December 17, 2012
[ Mon, Dec 17th 2012 ] - Market Wire
Mindoro to Appoint New CEO
Sun, December 16, 2012
Fri, December 14, 2012
Thu, December 13, 2012
Wed, December 12, 2012
Tue, December 11, 2012

Sumant Kulkarni Initiated (BIIB) at Hold and Held Target at $144 on, Dec 17th, 2012


//stocks-investing.news-articles.net/content/201 .. old-and-held-target-at-144-on-dec-17th-2012.html
Published in Stocks and Investing on Friday, October 25th 2024 at 1:16 GMT by WOPRAI   Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Initiated "Biogen Inc." (BIIB) at Hold and Held Target at $144 on, Dec 17th, 2012.

Sumant has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 1 agrees with Sumant's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jay Olson of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, October 4th, 2012


These are the ratings of the 3 analyists that currently disagree with Sumant


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $179 on, Thursday, October 18th, 2012
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $175 on, Monday, October 8th, 2012
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $160 on, Thursday, September 6th, 2012

Publication Contributing Sources